Host-microbe interaction in HLA-B27-associated diseases

Annals of Medicine

Volumn 29, Issue 2, 1997, Pages 153-157

  Granfors, Kaisa ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Ankylosing spondylitis; HLA B27; Reactive arthritis; Salmonella; Yersinia

Indexed keywords

HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; BACTERIAL INFECTION; HUMAN; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SALMONELLA; SPONDYLOARTHROPATHY; YERSINIA;

EID: 0030994399     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709113703     Document Type: Article

References (27)

1. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of Spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
2. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973; 1: 904-7.
3. Schlosstein L, Terasaki PI, Bluestone R, Person CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704-6.
4. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheum Scand 1969; 15: 232-53.
5. Grantors K. Do bacterial antigens cause reactive arthritis? Rheum Dis Clin North Am 1992; 18: 37-48.
6. Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HLA-B27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974; 17: 521-6.
7. Leirisalo M, Skylv G, Kousa M, et al. Follow-up study of patients with Reiter's disease and reactive arthritis with special reference to HLA-B27. Arthritis Rheum 1982; 25: 249-59.
8. Inman RD, Scofield RH. Etiopathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 1994; 6: 360-70.
9. Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 1995; 38: 1547-54.
10. Burmester GR, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N. Immunology of reactive arthritides. Annu Rev Immunol 1995; 13: 229-50.
11. Feltkamp TEW, Khan M, Lopez de Castro JA. The pathogenetic role of HLA-B27. Immunol Today 1996; 17: 5-7.
12. Mäki-lkola O, Granfors K. Salmonella-triggered reactive arthritis. Lancet 1992; 339: 1096-8.
13. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994; 53: 100-5.
14. Granfors K, Ogasawara M, Hill JL, et al. Analysis of IgA anti-lipopolysaccharide antibodies in Versinia-triggered reactive arthritis. J Infect Dis 1989; 159: 1142-7.
15. Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216-21.
16. Granfors K, Jalkanen S, Lindberg AA, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 335: 685-8.
17. Granfors K, Jalkanen S, Toivanen P, Koski J, Lindberg AA. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol 1992; 19: 500.
18. Granfors K, Toivanen A. IgA-anti-Versinia antibodies in Yersinia triggered reactive arthritis. Ann Rheum Dis 1986; 45: 561-5.
19. Ebringer A. Ankylosing spondylitis is caused by Klebsiella: evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin North Am 1992; 18: 105-21.
20. Ebringer RW, Cawdell DR, Cowling P, Ebringer A. Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease. Ann Rheum Dis 1978; 37: 16-151.
21. Trull A, Ebringer A, Panayi G, Ebringer R, James DC. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol 1984; 55: 74-80.
22. Mäki-lkola O, Nissilä M, Lehtinen K, Leirisalo-Repo M, Toivanen P, Granfors K. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis. Br J Rheumatol 1995; 34: 413-7.
23. Sahly H, Podschun R, Sass R, Broker B, Kekow J, Gross WL. Serum antibodies to Klebsiella capsular polysaccharides in ankylosing spondylitis. Arthritis Rheum 1994; 37: 754-9.
24. Nissilä M, Lahesmaa R, Leirisalo-Repo M, Lehtinen K, Toivanen P, Granfors K. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in AS: effect of sulfasalazine treatment. J Rheumatol 1994; 21: 2082-7.
25. Finlay BB, Falkow S. Salmonella as an intracellular parasite. Mol Microbiol 1989; 3: 1833-41.
26. Pierson DE. Mechanisms of Yersinia entry into mammalian cells. In: Miller VL, Kaper JB, Portnoy DA, Isberg RR, eds. Molecular Genetics of Bacterial Pathogenesis. Washington, DC: ASM Press, 1994: 235-48.
27. Gripenberg-Lerche C, Skurnik M, Zhang L, Söderström K-O, Toivanen P. Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun 1994; 62: 5568-75.